Literature DB >> 11178339

Anti-anaerobic activity of antibacterial agents.

A Bryskier1.   

Abstract

The first very effective bactericidal anti-anaerobic drug was metronidazole, introduced in clinical practice in the early 1980s. Sometimes penicillin G and chloramphenicol were used successfully in some anaerobic infections. However, this result was most likely due to Gram-positive anaerobic infections (e.g., Clostridium perfringens). Very rapidly, the anti-anaerobic armamentarium was extended with clindamycin, cefoxitin, imipenem and co-amoxyclav or piperacillin-tazobactam. The resistance rate to metronidazole and imipenem remains low but clindamycin has seen an importance decrease in bacterial susceptibility. New additional drugs could be very helpful to overcome resistance and adverse events. The novelties in this field are fluoroquinolones, which exhibit a good activity against Gram-positive cocci and anaerobes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11178339     DOI: 10.1517/13543784.10.2.239

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  5 in total

Review 1.  The aetiology of bacterial vaginosis.

Authors:  Y Turovskiy; K Sutyak Noll; M L Chikindas
Journal:  J Appl Microbiol       Date:  2011-03-14       Impact factor: 3.772

Review 2.  Optimal treatment of infected diabetic foot ulcers.

Authors:  Edward B Jude; Philip F Unsworth
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

3.  Activities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates.

Authors:  David W Hecht; J R Osmolski
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

4.  Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota.

Authors:  Federica Cruciani; Patrizia Brigidi; Fiorella Calanni; Vittoria Lauro; Raffaella Tacchi; Gilbert Donders; Klaus Peters; Secondo Guaschino; Beatrice Vitali
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

5.  Effect of antibiotic pre-treatment and pathogen challenge on the intestinal microbiota in mice.

Authors:  Tadasu Iizumi; Takako Taniguchi; Wataru Yamazaki; Geraldine Vilmen; Alexander V Alekseyenko; Zhan Gao; Guillermo I Perez Perez; Martin J Blaser
Journal:  Gut Pathog       Date:  2016-11-18       Impact factor: 4.181

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.